探索β-乳酸与DacB1的相互作用:揭开对抗耐药性Mycobacterium结核病的最佳疗法
Mary Nantongo1,2, David C Nguyen3, Eunjeong Shin2,4
1Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU), Cleveland, Ohio, USA.
mBio
|July 10, 2025
概括
结核病 (TB) 治疗可以通过重新使用β-乳糖抗生素来改善. 像伊米佩内姆这样的卡巴类药物有效地抑制了Mtb DacB1酶,显示出对抗耐药性Mycobacterium结核病的组合疗法的希望.
科学领域:
- 微生物学与传染病的研究
- 药物发现和开发 药物发现和开发
- 结构生物学 结构生物学
背景情况:
- 结核病 (TB) 仍然是一个全球卫生挑战,抗药性Mycobacterium tuberculosis (Mtb) 菌株的增加限制了治疗选择.
- 目前针对耐药结核病的治疗方法往往是有毒的,昂贵的,缺乏有效性,这凸显了对新型治疗策略的需求.
- 贝塔乳酸抗生素 (BLs) 历来对Mtb无效,正在重新评估结核病治疗,通过向像DacB1.1这样的必需酶来治疗结核病.
研究的目的:
- 通过向Mtb DacB1酶,研究重新利用β-乳糖抗生素 (BLs) 治疗结核病 (TB) 的潜力.
- 使用生物物理和质谱技术阐明各种BL和DacB1之间的结合相互作用.
- 探索双BL疗法和BL/β-乳糖酶抑制剂组合对Mtb.的疗效.
主要方法:
- 对各种BL和对Mtb菌株的抑制剂进行了最小抑制度 (MIC) 测定.
- 定时电喷射电离质谱仪 (ESI-MS) 用于捕获和分析DacB1-BL乙烯酸酶添加物.
- 差分扫描度测量 (DSF) 和循环二元化 (CD) 用于评估在BL结合时DacB1的结构变化.
- 进行了分子建模和对接研究,以了解DacB1活性部位内的结合相互作用.
主要成果:
- 结合BLs (imipenem,meropenem,tebipenem) 与阿莫西西林, ceftriaxone 或β-乳糖酶抑制剂 (clavulanate,durlobactam) 的组合可以降低Mtb MICs.
- 据ESI-MS证实,DacB1与卡巴烯 (imipenem,meropenem,tebipenem) 之间存在乙酶添加物,这表明直接结合.
- DSF和CD显示,DacB1在BL结合时经历物理和结构变化,而碳烯则表现出更快的相互作用.
- 分子建模在DacB1的活性部位中确定了保守的动机,并揭示了与碳烯的有利相互作用,解释了它们的结合疗效.
结论:
- 碳烯,特别是伊米,表现出对Mtb DacB1酶的有效结合,表明它们作为结核病治疗药物的潜力.
- 双BL疗法和BL/β-乳糖酶抑制剂组合显示出增强抗生素对Mtb.有效性的承诺.
- 重新利用BLs,特别是卡巴,为打击耐药结核病提供了具有成本效益的策略,并需要进一步的临床研究.
相关概念视频
Pulmonary Tuberculosis V
243
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
243
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Development of Antibiotic Resistance
219
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
219
Defense Against Bacterial Pathogens
1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Pulmonary Tuberculosis I
331
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
331


